Biopharmaceutical Company.
Monitored issues related to S. 2360/H.R. 4679: Stop Corporate Inversions Act of 2014 in the context of corporate acquisition activity. Education about access to therapies for children at risk of developing RSV (Respiratory Syncytial Virus), specifically with respect to guidelines by the American Academy of Pediatrics (AAP).
Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).H.R. 4299: Improving Regulatory Transparency for New Medical Therapies Act. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program.
TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX